• About us
• Contact

Advertisement

Product › Details

FXR agonist

	Next higher product group	pharmaceutical_o
	Status	2006-05-16 development p1 existent
	Organisation	Intercept Pharmaceuticals Inc.

Record changed: 2023-07-10

Advertisement

More documents for FXR agonist

• [1] Accession Therapeutics Ltd.. (7/19/23). "Press Release: Chief Business Officer Appointed at Accession Therapeutics as Company Prepares for Clinical Trials". Oxford....
• [2] Accession Therapeutics Ltd.. (11/21/22). "Press Release: Accession Therapeutics Raises £16.6m to Advance Potent Immunotherapies towards Clinical Trials". Oxford....
• [3] Accession Therapeutics Ltd.. (1/26/22). "Press Release: Cancer Leader Professor Alan Parker Joins Accession Therapeutics. Co-inventor of Trocept platform to Guide Immuno-oncology Pipeline Growth". Oxford....
• [4] Accession Therapeutics Ltd.. (9/20/21). "Press Release: Bent Jakobsen Starts Novel Immune-oncology Firm Accession Therapeutics, Primavera Venture Partners and Birk Venture among First Investors". Oxford....
• [5] Terns Pharmaceuticals, Inc.. (1/5/21). "Press Release: Terns Closes $87 Million Series C Financing to Advance Nash Portfolio". Foster City, CA....
• [6] Gilead Sciences, Inc.. (4/12/19). "Press Release: Gilead Sciences and Novo Nordisk Announce Intent to Initiate a Clinical Collaboration in NASH". Foster City & Bagsværd....
• [7] Metacrine, Inc.. (6/13/18). "Press Release: Metacrine Completes Dosing of First Cohort in Phase 1 Trial of MET409, a Novel Non-Bile Acid FXR Agonist". San Diego, CA....
• [8] Enyo Pharma S.A.. (6/4/18). "Press Release: Enyo Pharma Raises €40 Million in Series B Fundraising". Lyon....
• [9] Enyo Pharma S.A.. (2/27/18). "Press Release: Enyo Pharma Strengthens Its Leadership Team with a NASH Expert and Announces that Its Phase Ib Trial in Chronic HBV Infected Patients is on Track with Its FXR Agonist EYP001". Lyon....
• [10] Enyo Pharma S.A.. (5/10/17). "Press Release: Enyo Pharma Strengthens Its Business Team to Support International Growth". Lyon....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.